Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy

Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut 06510.

Technetium-99m isonitrile is a new myocardial perfusion imaging agent that accumulates according to the distribution of myocardial blood flow. However, unlike thallium-201, it does not redistribute over time. This imaging agent was used with serial quantitative planar imaging to assess the initial risk area of infarction, its change over time and the relation to infarct-related artery patency in 30 patients with a first acute myocardial infarction. Twenty-three of 30 patients were treated with recombinant tissue-type plasminogen activator (rt-PA) within 4 h after the onset of chest pain. Seven patients were treated in the conventional manner without thrombolytic therapy. Technetium-99m isonitrile was injected before or at the initiation of thrombolytic therapy, and imaging was performed several hours later. These initial images demonstrated the area at risk. Repeat imaging was performed 18 to 48 h later and at 6 to 14 days after the onset of myocardial infarction to visualize the ultimate extent of infarction. The initial area at risk varied greatly (range defect integral 2 to 61) both in patients treated with rt-PA and in those who received conventional treatment. For the total group, the initial imaging defect decreased in size in 20 patients and was unchanged or larger in 10 patients. Patients with a patent infarct-related artery had a significantly greater decrease in defect size than did patients with persistent coronary occlusion (-51 +/- 38% versus -1 +/- 26%, p = 0.0001). All patients with a decrease in defect size greater than 30% had a patent infarct-related artery. In 12 patients who also had predischarge quantitative exercise thallium-201 imaging, good agreement existed between the extent and severity of myocardial perfusion defect on the last technetium-99m isonitrile study before discharge and that noted on delayed thallium-201 imaging. It is concluded that serial planar technetium-99m isonitrile myocardial imaging in patients with acute myocardial infarction undergoing thrombolytic therapy offers a new quantitative noninvasive approach for assessment of the initial risk zone as well as the success of reperfusion.

This article has been cited by other articles:

				A. H. Aletras, G. S. Tilak, A. Natanzon, L.-Y. Hsu, F. M. Gonzalez, R. F. Hoyt Jr, and A. E. Arai Retrospective Determination of the Area at Risk for Reperfused Acute Myocardial Infarction With T2-Weighted Cardiac Magnetic Resonance Imaging: Histopathological and Displacement Encoding With Stimulated Echoes (DENSE) Functional Validations Circulation, April 18, 2006; 113(15): 1865 - 1870. [Abstract] [Full Text] [PDF]

				A. Natanzon, A. H. Aletras, L.-Y. Hsu, and A. E. Arai Determining Canine Myocardial Area at Risk with Manganese-enhanced MR Imaging Radiology, September 1, 2005; 236(3): 859 - 866. [Abstract] [Full Text] [PDF]

				A. C. Lapeyre III, E. Klodas, P. J. Rogers, L. J. Sinak, T. C. Hammell, M. K. O'Connor, and R. J. Gibbons Quantitation of Regional Ejection Fractions Using Gated Tomographic Imaging With 99mTc-Sestamibi Chest, March 1, 2005; 127(3): 778 - 786. [Abstract] [Full Text] [PDF]

				G. K. Lund, A. Stork, M. Saeed, M. P. Bansmann, J. H. Gerken, V. Muller, J. Mester, C. B. Higgins, G. Adam, and T. Meinertz Acute Myocardial Infarction: Evaluation with First-Pass Enhancement and Delayed Enhancement MR Imaging Compared with 201Tl SPECT Imaging Radiology, July 1, 2004; 232(1): 49 - 57. [Abstract] [Full Text] [PDF]

				G. Ndrepepa, J. Mehilli, M. Schwaiger, H. Schuhlen, S. Nekolla, S. Martinoff, C. Schmitt, J. Dirschinger, A. Schomig, and A. Kastrati Prognostic Value of Myocardial Salvage Achieved by Reperfusion Therapy in Patients with Acute Myocardial Infarction J. Nucl. Med., May 1, 2004; 45(5): 725 - 729. [Abstract] [Full Text] [PDF]

				R. Sciagra, S. Sestini, L. Bolognese, G. Cerisano, P. Buonamici, and A. Pupi Comparison of Dobutamine Echocardiography and 99mTc-Sestamibi Tomography for Prediction of Left Ventricular Ejection Fraction Outcome After Acute Myocardial Infarction Treated with Successful Primary Coronary Angioplasty J. Nucl. Med., January 1, 2002; 43(1): 8 - 14. [Abstract] [Full Text] [PDF]

				G. L. Schaer, L. J. Spaccavento, K. F. Browne, K. A. Krueger, D. Krichbaum, J. M. Phelan, W. O. Fletcher, C. L. Grines, S. Edwards, M. K. Jolly, et al. Beneficial Effects of RheothRx Injection in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction: Results of a Randomized, Double-Blind, Placebo-Controlled Trial Circulation, August 1, 1996; 94(3): 298 - 307. [Abstract] [Full Text]

				E. T. Hasche, C. Fernandes, S. B. Freedman, and R. W. Jeremy Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans Circulation, August 15, 1995; 92(4): 710 - 719. [Abstract] [Full Text]

				V. Sansoy, D. K. Glover, D. D. Watson, M. Ruiz, W. H. Smith, J. P. Simanis, and G. A. Beller Comparison of Thallium-201 Resting Redistribution With Technetium-99m Sestamibi Uptake and Functional Response to Dobutamine for Assessment of Myocardial Viability Circulation, August 15, 1995; 92(4): 994 - 1004. [Abstract] [Full Text]

				T. D. Miller, T. F. Christian, M. R. Hopfenspirger, D. O. Hodge, B. J. Gersh, and R. J. Gibbons Infarct Size After Acute Myocardial Infarction Measured by Quantitative Tomographic 99mTc Sestamibi Imaging Predicts Subsequent Mortality Circulation, August 1, 1995; 92(3): 334 - 341. [Abstract] [Full Text]

				M.G. Niemeyer, E.E. van der Wall, A.F.M. Kuijper, A.T. Cleophas, and E.K.J. Pauwels Nuclear Cardiology, Current Applications in Clinical Practice Angiology, July 1, 1995; 46(7): 591 - 602. [Abstract] [PDF]

				W. G. Hundley, G. D. Clarke, C. Landau, R. A. Lange, J. E. Willard, L. D. Hillis, and R. M. Peshock Noninvasive Determination of Infarct Artery Patency By Cine Magnetic Resonance Angiography Circulation, March 1, 1995; 91(5): 1347 - 1353. [Abstract] [Full Text]

				B. L. Zaret, P. Rigo, F. J.T. Wackers, R. C. Hendel, S. H. Braat, A. S. Iskandrian, B. S. Sridhara, D. Jain, R. Itti, A. N. Serafini, et al. Myocardial Perfusion Imaging With 99mTc Tetrofosmin : Comparison to 201Tl Imaging and Coronary Angiography in a Phase III Multicenter Trial Circulation, January 15, 1995; 91(2): 313 - 319. [Abstract] [Full Text]

				A. J. Moss, R. E. Goldstein, W. J. Hall, J. T. Bigger Jr, J. L. Fleiss, H. Greenberg, M. Bodenheimer, R. J. Krone, F. I. Marcus, F. J. Th. Wackers, et al. Detection and Significance of Myocardial Ischemia in Stable Patients After Recovery From an Acute Coronary Event JAMA, May 12, 1993; 269(18): 2379 - 2385. [Abstract] [PDF]

				M. Santomauro, A. Cuocolo, L. Celentano, S. Ferraro, L. Pace, C. Pappone, G. Maddalena, M. Salvatore, and M. Chiariello Diagnosis of Coronary Artery Disease with Tc 99m-Methoxy Isobutil Isonitrile and Transesophageal Pacing Angiology, October 1, 1992; 43(10): 818 - 825. [Abstract] [PDF]

				H. Tomoda Electrocardiographic Prediction of the Success of Coronary Reperfusion by Intravenous Thrombolytic Therapy: An Experimental Study Angiology, August 1, 1992; 43(8): 631 - 640. [Abstract] [PDF]

				T. F. Christian, I. P. Clements, T. Behrenbeck, K. C. Huber, J. H. Chesebro, B. J. Gersh, and R. J. Gibbons Limitations of the Electrocardiogram in Estimating Infarction Size after Acute Reperfusion Therapy for Myocardial Infarction Ann Intern Med, February 15, 1991; 114(4): 264 - 270. [Abstract] [PDF]

				D. W. Krichbaum and D. A. Trivedi Thrombolytic Therapy in Acute Myocardial Infarction Journal of Pharmacy Practice, January 1, 1990; 3(5): 332 - 348. [PDF]

				AN IMPORTANT APPLICATION FOR A NEW CARDIAC IMAGING AGENT Journal Watch (General), October 20, 1989; 1989(1020): 7 - 7. [Full Text]